Patents

US 12644122 B2: Compositions and methods for treating amyotrophic lateral sclerosis

Granted
2026-06-02
Filed
2022-03-31 application 17710418
Type
Utility · 8 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

The present disclosure features methods and compositions for treating amyotrophic lateral sclerosis (ALS). The disclosed methods comprise administering to a subject having or suspected of having ALS a hematopoietic stem progenitor cell expressing at least one neuroprotective agent. The compositions disclosed comprise hematopoietic stem progenitor cells transduced to express a neuroprotective agent.

Source: PTBLXML, file of 2026-06-02 (ipgb20260602.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
The Children's Medical Center Corporation 717 patentsUS company or organizationBoston, MATHE CHILDREN'S MEDICAL CENTER CORPORATION State business registration FUZZY medium confidence: same name (legal endings aside) and statePTBLXML, file of 2026-06-02
Dana-Farber Cancer Institute, Inc. 892 patentsUS company or organizationBoston, MADANA-FARBER CANCER INSTITUTE, INC. Federal lobbying client EXACT high confidence: identical full name and state
DANA-FARBER CANCER INSTITUTE Nonprofit FUZZY medium confidence: same name (governing-board words and legal endings aside) and state
PTBLXML, file of 2026-06-02

Inventors

InventorPlacePatentsPerson pageSource
Alessandra BiffiBoston, MA10PTBLXML, file of 2026-06-02
Marco PevianiBoston, MA3PTBLXML, file of 2026-06-02
Francisco J. Molina-EstevezBoston, MAPTBLXML, file of 2026-06-02

CPC categories

SubclassCategoryFirst groupSource
C12NMicroorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture mediaC12N15/1137PTBLXML, file of 2026-06-02
A61KPreparations for medical, dental or toiletry purposesA61K35/28PTBLXML, file of 2026-06-02
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P25/28PTBLXML, file of 2026-06-02

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2026-02-26Assignment
Assignment of assignor's interest
PEVIANI, MARCO signed 2022-03-11DANA-FARBER CANCER INSTITUTE, INC. BOSTON, MA73911/768PASDL, file of 2026-10-15
2026-02-26Assignment
Assignment of assignor's interest
MOLINA-ESTEVEZ, FRANCISCO J. signed 2022-04-20DANA-FARBER CANCER INSTITUTE, INC. BOSTON, MA73911/724PASDL, file of 2026-10-15
2026-02-26Assignment
Assignment of assignor's interest
BIFFI, ALESSANDRA signed 2022-01-19THE CHILDREN'S MEDICAL CENTER CORPORATION BOSTON, MA
DANA-FARBER CANCER INSTITUTE, INC. BOSTON, MA
73911/707PASDL, file of 2026-10-15

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.